What is Coloplast A/S (CLPBF)?

Coloplast A/S (CLPBF) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of CLPBF?

The current price of CLPBF is $71.24. Prices are updated in real time on Stocks360.

What is CLPBF's price-to-earnings (PE) ratio?

CLPBF's trailing twelve-month PE ratio is 38.91, based on current price and earnings per share data available on Stocks360.

What is CLPBF's market capitalization?

CLPBF's market capitalization is $14,772,906,151.00, placing it in the large-cap tier.

Does CLPBF pay a dividend?

Yes. CLPBF has a trailing twelve-month dividend yield of 0.05%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Coloplast A/S (CLPBF)

Stock analysis · OTC · Healthcare · Medical - Instruments & Supplies

$71.24

Market Cap

$14.77B

PE (TTM)

38.91

EPS (TTM)

N/A

Dividend Yield

4.82%

Beta

0.55

Day Range

$65.16 – $71.24

52-wk Range

$56.81 – $95.43

Avg Volume

N/A

Volume

3.00

Coloplast A/S (CLPBF) is a publicly traded company in the Healthcare sector. Latest price: $71.24. Market cap $14.77B. Trailing PE 38.91. Dividend yield 4.82%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $92.80 2026-10-29 · $71.24 (-23.23%)

Earnings

Most Recent

Aug 18, 2026

EPS $1.00 vs est. $0.93

Beat by $0.07

Next Earnings

Nov 3, 2026

EPS estimate $0.89

Proprietary Signals

Signal snapshot temporarily unavailable.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasi…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	38.91×
P/S (TTM)	3.78×
P/B	8.04×
P/FCF (TTM)	17.15×
EV / EBITDA	11.02×
EV / Sales	4.59×
Earnings Yield	2.57%
Free Cash Flow Yield	5.83%
Dividend Yield	4.82%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$130.49B
Revenue (TTM)	$28.44B
Net Income (TTM)	$2.76B
Free Cash Flow (TTM)	$6.61B
Net Debt	$22.99B
Working Capital	$3.74B
Gross Margin	58.50%
Operating Margin	26.35%
Net Margin	9.71%
Return on Equity	19.69%
Return on Invested Capital	12.07%